Vanessa Carle serves as Executive at Lexaria Bioscience Corp., where they oversee executive responsibilities. Since joining the company, Vanessa Carle has executed 3 insider transactions totaling $11.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 29, 2025 involved purchasing 750 shares valued at $683.
Vanessa Carle currently holds 750 shares of Lexaria Bioscience Corp. (LEXX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Vanessa Carle has been a net seller of LEXX stock. They have purchased $683 and sold $10.3K worth of shares.
Vanessa Carle's most recent insider trade was on Jul 29, 2025, when they purchased 750 shares at $0.91 per share.
Get notified when new Form 4 filings are submitted
| $4.00 |
| Discretionary |
| May 14, 2024 | LEXX | $2.9K | Option Exercise | 2,500 | $1.15 | Discretionary |